世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ジカウイルス治療薬の世界市場 2022-2026


Global Zika Virus Therapeutics Market 2022-2026

ジカウイルス治療薬の世界市場2022-2026年 Technavioはジカウイルス治療薬市場を監視しており、2022-2026年の間に49億7000万ドルの成長が見込まれ、予測期間中にCAGR5.25%で加速しています。ジカウイルス治療薬... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年5月24日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

ジカウイルス治療薬の世界市場2022-2026年
Technavioはジカウイルス治療薬市場を監視しており、2022-2026年の間に49億7000万ドルの成長が見込まれ、予測期間中にCAGR5.25%で加速しています。ジカウイルス治療薬市場に関する当レポートでは、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、ジカウイルス感染の質的診断のための血清検査キットの利用可能性、感染の高い発生率、ジカウイルス感染および関連する併存疾患の疾病負担によって牽引されています。
ジカウイルス治療薬市場の分析には、製品セグメントや地理的な状況も含まれます。
Technavioのジカウイルス治療薬市場は、以下のようにセグメント化されています。
製品別
- アセトアミノフェン
- その他の非ステロイド性抗炎症薬
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間のジカウイルス治療薬市場の成長を促進する主要な理由の1つとして、ワクチン開発を促進するための政府および民間組織による取り組みが増加していることを挙げています。また、ジカウイルス感染が公衆衛生上の緊急事態に分類され、ワクチン開発のための新しいアプローチが、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ジカウイルス治療薬市場に関する当レポートは、以下の分野を対象としています。
- ジカウイルス治療薬市場のサイジング
- ジカウイルス治療薬市場の予測
- ジカウイルス治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Johnson and Johnson、Aurobindo Pharma Ltd., Granules India Ltd., Perrigo Co., Sun Pharmaceutical Industries Ltd.を含むいくつかのジカウイルス治療薬市場の主要ベンダーに関する詳細分析を提供しています。Plc、Sun Pharmaceutical Industries Ltd.、Bharat Biotech Ltd.、Emergent BioSolutions Inc.、Takeda Pharmaceutical Co.Ltd.、GeoVax Labs Inc.、IMV Inc.、Inovio Pharmaceuticals Inc.、Moderna Inc.、Merck and Co.Inc.、Valneva SE。また、ジカウイルス治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/zika-virus-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Acetaminophen - Market size and forecast 2021-2026
o Exhibit 28: Chart on Acetaminophen - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Acetaminophen - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Acetaminophen - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Acetaminophen - Year-over-year growth 2021-2026 (%)
o 5.4 Other NSAIDs - Market size and forecast 2021-2026
o Exhibit 32: Chart on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Other NSAIDs - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Other NSAIDs - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Denmark - Market size and forecast 2021-2026
o Exhibit 62: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Denmark - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Aurobindo Pharma Ltd.
o Exhibit 85: Aurobindo Pharma Ltd. - Overview
o Exhibit 86: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 87: Aurobindo Pharma Ltd. - Key offerings
o 10.4 Bharat Biotech Ltd.
o Exhibit 88: Bharat Biotech Ltd. - Overview
o Exhibit 89: Bharat Biotech Ltd. - Product / Service
o Exhibit 90: Bharat Biotech Ltd. - Key news
o Exhibit 91: Bharat Biotech Ltd. - Key offerings
o 10.5 Emergent BioSolutions Inc.
o Exhibit 92: Emergent BioSolutions Inc. - Overview
o Exhibit 93: Emergent BioSolutions Inc. - Product / Service
o Exhibit 94: Emergent BioSolutions Inc. - Key news
o Exhibit 95: Emergent BioSolutions Inc. - Key offerings
o 10.6 GeoVax Labs Inc.
o Exhibit 96: GeoVax Labs Inc. - Overview
o Exhibit 97: GeoVax Labs Inc. - Product / Service
o Exhibit 98: GeoVax Labs Inc. - Key news
o Exhibit 99: GeoVax Labs Inc. - Key offerings
o 10.7 Granules India Ltd.
o Exhibit 100: Granules India Ltd. - Overview
o Exhibit 101: Granules India Ltd. - Product / Service
o Exhibit 102: Granules India Ltd. - Key news
o Exhibit 103: Granules India Ltd. - Key offerings
o 10.8 IMV Inc.
o Exhibit 104: IMV Inc. - Overview
o Exhibit 105: IMV Inc. - Product / Service
o Exhibit 106: IMV Inc. - Key news
o Exhibit 107: IMV Inc. - Key offerings
o 10.9 Johnson and Johnson
o Exhibit 108: Johnson and Johnson - Overview
o Exhibit 109: Johnson and Johnson - Business segments
o Exhibit 110: Johnson and Johnson - Key news
o Exhibit 111: Johnson and Johnson - Key offerings
o Exhibit 112: Johnson and Johnson - Segment focus
o 10.10 Perrigo Co. Plc
o Exhibit 113: Perrigo Co. Plc - Overview
o Exhibit 114: Perrigo Co. Plc - Business segments
o Exhibit 115: Perrigo Co. Plc - Key offerings
o Exhibit 116: Perrigo Co. Plc - Segment focus
o 10.11 Sun Pharmaceutical Industries Ltd.
o Exhibit 117: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 118: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 119: Sun Pharmaceutical Industries Ltd. - Key offerings
o 10.12 Takeda Pharmaceutical Co. Ltd.
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 123: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 124: Inclusions checklist
o Exhibit 125: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 126: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 127: Research methodology
o Exhibit 128: Validation techniques employed for market sizing
o Exhibit 129: Information sources
o 11.5 List of abbreviations
o Exhibit 130: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Acetaminophen - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Acetaminophen - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Acetaminophen - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Acetaminophen - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Other NSAIDs - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Other NSAIDs - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Aurobindo Pharma Ltd. - Overview
Exhibits86: Aurobindo Pharma Ltd. - Product / Service
Exhibits87: Aurobindo Pharma Ltd. - Key offerings
Exhibits88: Bharat Biotech Ltd. - Overview
Exhibits89: Bharat Biotech Ltd. - Product / Service
Exhibits90: Bharat Biotech Ltd. - Key news
Exhibits91: Bharat Biotech Ltd. - Key offerings
Exhibits92: Emergent BioSolutions Inc. - Overview
Exhibits93: Emergent BioSolutions Inc. - Product / Service
Exhibits94: Emergent BioSolutions Inc. - Key news
Exhibits95: Emergent BioSolutions Inc. - Key offerings
Exhibits96: GeoVax Labs Inc. - Overview
Exhibits97: GeoVax Labs Inc. - Product / Service
Exhibits98: GeoVax Labs Inc. - Key news
Exhibits99: GeoVax Labs Inc. - Key offerings
Exhibits100: Granules India Ltd. - Overview
Exhibits101: Granules India Ltd. - Product / Service
Exhibits102: Granules India Ltd. - Key news
Exhibits103: Granules India Ltd. - Key offerings
Exhibits104: IMV Inc. - Overview
Exhibits105: IMV Inc. - Product / Service
Exhibits106: IMV Inc. - Key news
Exhibits107: IMV Inc. - Key offerings
Exhibits108: Johnson and Johnson - Overview
Exhibits109: Johnson and Johnson - Business segments
Exhibits110: Johnson and Johnson - Key news
Exhibits111: Johnson and Johnson - Key offerings
Exhibits112: Johnson and Johnson - Segment focus
Exhibits113: Perrigo Co. Plc - Overview
Exhibits114: Perrigo Co. Plc - Business segments
Exhibits115: Perrigo Co. Plc - Key offerings
Exhibits116: Perrigo Co. Plc - Segment focus
Exhibits117: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits118: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits119: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits123: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Zika Virus Therapeutics Market 2022-2026
Technavio has been monitoring the zika virus therapeutics market and it is poised to grow by $ 4.97 billion during 2022-2026, accelerating at a CAGR of 5.25% during the forecast period. Our report on the zika virus therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the availability of serology kit for qualitative diagnosis of zika virus infection, high incidence rate of infection, and disease burden of zika virus infection and associated comorbidities.
The zika virus therapeutics market analysis includes the product segment and geographic landscape.
Technavio's zika virus therapeutics market is segmented as below:
By Product
• Acetaminophen
• Other NSAIDs
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the increasing efforts by government and private organizations to facilitate vaccine development as one of the prime reasons driving the zika virus therapeutics market growth during the next few years. Also, classification of zika virus infection as a public health emergency and novel approach for vaccine development will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on zika virus therapeutics market covers the following areas:
• Zika virus therapeutics market sizing
• Zika virus therapeutics market forecast
• Zika virus therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading zika virus therapeutics market vendors that include Johnson and Johnson, Aurobindo Pharma Ltd., Granules India Ltd., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., Bharat Biotech Ltd., Emergent BioSolutions Inc., Takeda Pharmaceutical Co. Ltd., GeoVax Labs Inc., IMV Inc., Inovio Pharmaceuticals Inc., Moderna Inc., Merck and Co. Inc., and Valneva SE. Also, the zika virus therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/zika-virus-therapeutics-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Acetaminophen - Market size and forecast 2021-2026
o Exhibit 28: Chart on Acetaminophen - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Acetaminophen - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Acetaminophen - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Acetaminophen - Year-over-year growth 2021-2026 (%)
o 5.4 Other NSAIDs - Market size and forecast 2021-2026
o Exhibit 32: Chart on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Other NSAIDs - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Other NSAIDs - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Denmark - Market size and forecast 2021-2026
o Exhibit 62: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Denmark - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Aurobindo Pharma Ltd.
o Exhibit 85: Aurobindo Pharma Ltd. - Overview
o Exhibit 86: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 87: Aurobindo Pharma Ltd. - Key offerings
o 10.4 Bharat Biotech Ltd.
o Exhibit 88: Bharat Biotech Ltd. - Overview
o Exhibit 89: Bharat Biotech Ltd. - Product / Service
o Exhibit 90: Bharat Biotech Ltd. - Key news
o Exhibit 91: Bharat Biotech Ltd. - Key offerings
o 10.5 Emergent BioSolutions Inc.
o Exhibit 92: Emergent BioSolutions Inc. - Overview
o Exhibit 93: Emergent BioSolutions Inc. - Product / Service
o Exhibit 94: Emergent BioSolutions Inc. - Key news
o Exhibit 95: Emergent BioSolutions Inc. - Key offerings
o 10.6 GeoVax Labs Inc.
o Exhibit 96: GeoVax Labs Inc. - Overview
o Exhibit 97: GeoVax Labs Inc. - Product / Service
o Exhibit 98: GeoVax Labs Inc. - Key news
o Exhibit 99: GeoVax Labs Inc. - Key offerings
o 10.7 Granules India Ltd.
o Exhibit 100: Granules India Ltd. - Overview
o Exhibit 101: Granules India Ltd. - Product / Service
o Exhibit 102: Granules India Ltd. - Key news
o Exhibit 103: Granules India Ltd. - Key offerings
o 10.8 IMV Inc.
o Exhibit 104: IMV Inc. - Overview
o Exhibit 105: IMV Inc. - Product / Service
o Exhibit 106: IMV Inc. - Key news
o Exhibit 107: IMV Inc. - Key offerings
o 10.9 Johnson and Johnson
o Exhibit 108: Johnson and Johnson - Overview
o Exhibit 109: Johnson and Johnson - Business segments
o Exhibit 110: Johnson and Johnson - Key news
o Exhibit 111: Johnson and Johnson - Key offerings
o Exhibit 112: Johnson and Johnson - Segment focus
o 10.10 Perrigo Co. Plc
o Exhibit 113: Perrigo Co. Plc - Overview
o Exhibit 114: Perrigo Co. Plc - Business segments
o Exhibit 115: Perrigo Co. Plc - Key offerings
o Exhibit 116: Perrigo Co. Plc - Segment focus
o 10.11 Sun Pharmaceutical Industries Ltd.
o Exhibit 117: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 118: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 119: Sun Pharmaceutical Industries Ltd. - Key offerings
o 10.12 Takeda Pharmaceutical Co. Ltd.
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 123: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 124: Inclusions checklist
o Exhibit 125: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 126: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 127: Research methodology
o Exhibit 128: Validation techniques employed for market sizing
o Exhibit 129: Information sources
o 11.5 List of abbreviations
o Exhibit 130: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Acetaminophen - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Acetaminophen - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Acetaminophen - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Acetaminophen - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Other NSAIDs - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Other NSAIDs - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Aurobindo Pharma Ltd. - Overview
Exhibits86: Aurobindo Pharma Ltd. - Product / Service
Exhibits87: Aurobindo Pharma Ltd. - Key offerings
Exhibits88: Bharat Biotech Ltd. - Overview
Exhibits89: Bharat Biotech Ltd. - Product / Service
Exhibits90: Bharat Biotech Ltd. - Key news
Exhibits91: Bharat Biotech Ltd. - Key offerings
Exhibits92: Emergent BioSolutions Inc. - Overview
Exhibits93: Emergent BioSolutions Inc. - Product / Service
Exhibits94: Emergent BioSolutions Inc. - Key news
Exhibits95: Emergent BioSolutions Inc. - Key offerings
Exhibits96: GeoVax Labs Inc. - Overview
Exhibits97: GeoVax Labs Inc. - Product / Service
Exhibits98: GeoVax Labs Inc. - Key news
Exhibits99: GeoVax Labs Inc. - Key offerings
Exhibits100: Granules India Ltd. - Overview
Exhibits101: Granules India Ltd. - Product / Service
Exhibits102: Granules India Ltd. - Key news
Exhibits103: Granules India Ltd. - Key offerings
Exhibits104: IMV Inc. - Overview
Exhibits105: IMV Inc. - Product / Service
Exhibits106: IMV Inc. - Key news
Exhibits107: IMV Inc. - Key offerings
Exhibits108: Johnson and Johnson - Overview
Exhibits109: Johnson and Johnson - Business segments
Exhibits110: Johnson and Johnson - Key news
Exhibits111: Johnson and Johnson - Key offerings
Exhibits112: Johnson and Johnson - Segment focus
Exhibits113: Perrigo Co. Plc - Overview
Exhibits114: Perrigo Co. Plc - Business segments
Exhibits115: Perrigo Co. Plc - Key offerings
Exhibits116: Perrigo Co. Plc - Segment focus
Exhibits117: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits118: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits119: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits123: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/07 10:27

155.63 円

167.26 円

203.27 円

ページTOPに戻る